TECH · BIO-TECHNE Corp · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-17 | Hippel James |
CFO |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. 36,459 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
36,459 |
| 2026-08-17 | Bohnen Shane |
SVP - General Counsel |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 18,432 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
18,432 |
| 2026-08-17 | Kelderman Kim |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 93,582 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
93,582 |
| 2026-08-17 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 23,985 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
23,985 |
| 2026-08-17 | Hippel James |
CFO |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. 7,479 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 7,480 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
22,438 |
| 2026-08-17 | Crouse Steven C. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 2,901 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 2,900 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
8,702 |
| 2026-08-17 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 4,921 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 4,920 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
14,762 |
| 2026-08-17 | Bohnen Shane |
SVP - General Counsel |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 3,781 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 3,782 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
11,344 |
| 2026-08-17 | Crouse Steven C. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 14,140 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
14,140 |
| 2026-08-17 | Herr Amy E. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Indirect)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 460 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 461 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
(I)
|
1,381 |
| 2026-08-17 | Kelderman Kim |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029. |
Restricted Stock Units
|
57,590 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. |
Restricted Stock Units
|
3,226 |
| 2026-08-15 | Crouse Steven C. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 1,379 restricted stock units vest on 8/15/2026. |
Restricted Stock Units
|
1,379 |
| 2026-08-15 | Kelderman Kim |
Director |
Other↓
Filing footnotes — Performance Stock Options (Right to Buy) (Direct)
On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. |
Performance Stock Options (Right to Buy)
|
22,389 |
| 2026-08-15 | Hippel James |
CFO |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
866 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Other↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
8,507 |
| 2026-08-15 | Herr Amy E. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Indirect)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. |
Restricted Stock Units
(I)
|
311 |
| 2026-08-15 | Bohnen Shane |
SVP - General Counsel |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. |
Restricted Stock Units
|
1,669 |
| 2026-08-15 | Herr Amy E. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Indirect)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. |
Restricted Stock Units
(I)
|
160 |
| 2026-08-15 | Kelderman Kim |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. |
Restricted Stock Units
|
11,785 |
| 2026-08-15 | Kelderman Kim |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. |
Restricted Stock Units
|
8,543 |
| 2026-08-15 | Crouse Steven C. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. |
Restricted Stock Units
|
2,176 |
| 2026-08-15 | Bohnen Shane |
SVP - General Counsel |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 49 restricted stock units vest on 8/15/2026. |
Restricted Stock Units
|
49 |
| 2026-08-15 | Bohnen Shane |
SVP - General Counsel |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
300 |
| 2026-08-15 | Hippel James |
CFO |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. |
Restricted Stock Units
|
4,010 |
| 2026-08-15 | Kelderman Kim |
Director |
Other↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
8,835 |
| 2026-08-15 | Bohnen Shane |
SVP - General Counsel |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. |
Restricted Stock Units
|
2,332 |
| 2026-08-15 | Hippel James |
CFO |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. |
Restricted Stock Units
|
4,903 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Tax↓
|
Common Stock
|
1,976 |
| 2026-08-15 | Herr Amy E. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Indirect)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 118 restricted stock units vest on 8/15/2026. |
Restricted Stock Units
(I)
|
118 |
| 2026-08-15 | Kelderman Kim |
Director |
Other↓
Filing footnotes — Performance Stock Options (Right to Buy) (Direct)
On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. |
Performance Stock Options (Right to Buy)
|
24,324 |
| 2026-08-15 | Kelderman Kim |
Director |
Convert↑
|
Common Stock
|
21,470 |
| 2026-08-15 | Hippel James |
CFO |
Other↓
Filing footnotes — Performance Stock Options (Right to Buy) (Direct)
On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. |
Performance Stock Options (Right to Buy)
|
34,982 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
567 |
| 2026-08-15 | Kelderman Kim |
Director |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
588 |
| 2026-08-15 | Crouse Steven C. |
Director |
Convert↑
|
Common Stock
|
5,423 |
| 2026-08-15 | Hippel James |
CFO |
Convert↑
|
Common Stock
|
9,779 |
| 2026-08-15 | Bohnen Shane |
SVP - General Counsel |
Convert↑
|
Common Stock
|
4,350 |
| 2026-08-15 | Kelderman Kim |
Director |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
554 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Other↓
Filing footnotes — Performance Stock Options (Right to Buy) (Direct)
On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. |
Performance Stock Options (Right to Buy)
|
22,898 |
| 2026-08-15 | Herr Amy E. |
Director |
Convert↑
|
Common Stock
(I)
|
589 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Convert↑
|
Common Stock
|
6,416 |
| 2026-08-15 | Bohnen Shane |
SVP - General Counsel |
Other↓
Filing footnotes — Performance Stock Option (Right to Buy) (Direct)
On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. |
Performance Stock Option (Right to Buy)
|
12,117 |
| 2026-08-15 | Hippel James |
CFO |
Tax↓
|
Common Stock
|
4,310 |
| 2026-08-15 | Crouse Steven C. |
Director |
Tax↓
|
Common Stock
|
1,947 |
| 2026-08-15 | Geist William |
PRESIDENT, PROTEIN SCIENCES |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. |
Restricted Stock Units
|
2,623 |
| 2026-08-15 | Hippel James |
CFO |
Other↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
12,999 |
| 2026-08-15 | Kelderman Kim |
Director |
Other↓
Filing footnotes — Performance Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. |
Performance Restricted Stock Units
|
8,319 |
| 2026-08-15 | Kelderman Kim |
Director |
Tax↓
|
Common Stock
|
10,821 |
| 2026-08-15 | Crouse Steven C. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. |
Restricted Stock Units
|
1,868 |